Skip to main content

How does radiation therapy or chemotherapy increase the risk of primary bone cancer?

 Radiation therapy and chemotherapy are common treatments for cancer. While they can be effective in treating cancer, they can also increase the risk of developing primary bone cancer. 


Radiation therapy uses high-energy rays or particles to kill cancer cells. It can cause damage to normal cells, including bone cells, which can lead to an increased risk of developing bone cancer[2][9]. The risk is higher in people who were treated when they were younger, especially as children, and those who were treated with higher doses of radiation. These cancers tend to develop many years, often decades, after the radiation therapy was given[2].


Chemotherapy is the use of drugs to treat cancer. Some chemotherapy drugs, such as alkylating agents, are linked with an increased risk of developing osteosarcoma[3][8]. Chemotherapy can also lead to significant bone loss, which increases the risk of osteoporosis and fractures[4][12].


It's important to note that having radiation therapy or chemotherapy for cancer does not mean that a person will definitely develop bone cancer. Most people who receive radiation therapy or chemotherapy don't develop bone cancer[2][5]. 


If you're concerned about your risk of developing bone cancer due to previous radiation therapy or chemotherapy, it's always best to talk to your doctor. They can provide more information about your individual risk and recommend any necessary screening or monitoring. 


##References

1. University of Rochester Medical Center. Primary bone cancer: risk factors. Retrieved from https://www.urmc.rochester.edu/encyclopedia/content.aspx?contentid=24885-1&contenttypeid=34

2. American Cancer Society. Risk Factors for Bone Cancer. Retrieved from https://www.cancer.org/cancer/types/bone-cancer/causes-risks-prevention/risk-factors.html

3. Cancer Research UK. Risks and causes | bone cancer Retrieved from https://www.cancerresearchuk.org/about-cancer/bone-cancer/risks-causes

4.PMC. Chemotherapy- and Irradiation-Induced Bone Loss in Adults with Solid Tumors. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417126/

5. Cancer Treatment Centers of America. Bone Cancer Causes & Risk Factors: Is it Hereditary? Retrieved from https://www.cancercenter.com/cancer-types/bone-cancer/risk-factors

6. National Cancer Institute. Primary Bone Cancer. Retrieved from https://www.cancer.gov/types/bone/bone-fact-sheet

7. Memorial Sloan Kettering Cancer Center. Bone Cancer Risk Factors. Retrieved from https://www.mskcc.org/cancer-care/types/bone/risk-factors

8. Cancer.Net. Bone Cancer (Sarcoma of Bone): Risk Factors. Retrieved from https://www.cancer.net/cancer-types/bone-cancer-sarcoma-bone/risk-factors

9. NCBI Bookshelf. The Science Behind Radiation Therapy How does radiation work to treat cancer? Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK564367/


Citation:

[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421962/

[2] https://www.cancer.org/cancer/types/bone-cancer/causes-risks-prevention/risk-factors.html

[3] https://www.cancerresearchuk.org/about-cancer/bone-cancer/risks-causes

[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417126/

[5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401480/

[6] https://www.cancer.org/cancer/types/bone-cancer/treating/radiation.html

[7] https://www.cancer.org/cancer/types/bone-cancer/treating/chemotherapy.html

[8] https://www.ncbi.nlm.nih.gov/books/NBK564367/

[9] https://www.cancer.org/content/dam/CRC/PDF/Public/6151.00.pdf

[10] https://www.urmc.rochester.edu/encyclopedia/content.aspx?contentid=24885-1&contenttypeid=34

[11] https://www.ncbi.nlm.nih.gov/books/NBK560830/

[12] https://www.cancer.gov/news-events/cancer-currents-blog/2020/bone-loss-chemotherapy-senescence

[13] https://www.cancer.gov/news-events/cancer-currents-blog/2019/bone-metastases-pain-single-radiation-dose

[14] https://www.cancer.net/cancer-types/bone-cancer-sarcoma-bone/risk-factors

[15] https://www.cancer.gov/types/bone/bone-fact-sheet

[16] https://www.cancer.org/cancer/types/osteosarcoma/treating/chemotherapy.html

[17] https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.21689

[18] https://pubmed.ncbi.nlm.nih.gov/8614005/

[19] https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/bone-cancer

[20] https://www.cancerresearchuk.org/about-cancer/bone-cancer/treatment/chemotherapy-for-bone-cancer

[21] https://www.frontiersin.org/articles/10.3389/fonc.2013.00073/full

[22] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507855/

[23] https://www.mayoclinic.org/diseases-conditions/bone-cancer/symptoms-causes/syc-20350217

[24] https://www.mskcc.org/cancer-care/types/bone/treatment/chemotherapy

[25] https://academic.oup.com/jnci/article/98/24/1794/2521950

[26] https://www.cancercenter.com/cancer-types/bone-cancer/risk-factors

[27] https://www.saintlukeskc.org/health-library/primary-bone-cancer-chemotherapy

[28] https://www.cancervic.org.au/cancer-information/types-of-cancer/bone_cancer/primary-bone-cancer-overview.html

[29] https://www.mskcc.org/cancer-care/types/bone/risk-factors

Comments

Popular posts from this blog

Flying Just Got a Lot More Expensive — and Tariffs Are Only the Beginning

 As trade tensions escalate between major economies, new tariff uncertainties are weighing heavily on airlines. The consequences will ripple far beyond boardrooms and airfields: travelers should expect higher ticket prices, fewer route options, and a possible reshaping of the global aviation landscape. Immediate Impacts: Airlines Navigate a New Set of Risks In the short term, airlines are grappling with a complex mix of operational challenges: First, the aircraft supply chain is under pressure. Trade disputes between the United States, the European Union, and China have complicated the procurement of new planes. Manufacturers like Boeing, Airbus, and China's state-backed COMAC are caught in the middle, creating delays and pricing uncertainty for carriers ( Reuters ). Fuel markets are similarly volatile. Airlines typically hedge fuel prices months in advance to avoid sudden cost spikes. However, unpredictable shifts in global oil prices—driven in part by trade instability—are u...

What’s it like to grow up in Vienna, Austria? | Young and European

Key Themes and Insights: City Overview 🏙️ Vienna is often referred to as the 'City of Music' and has consistently been voted the world's most livable city. ✨ The city balances open-mindedness with rich traditions, offering impressive infrastructure and educational opportunities. Living Environment 🏡 Sebi enjoys living in the eighth district, Josefstadt, known for its proximity to the city center but high rental prices. 💰 The average rent in Vienna is €9.80 per square meter, making it relatively affordable compared to other European cities, although this district is an exception. Education System 📚 Sebi attends one of the oldest schools in Vienna, where he studies multiple languages and engages in higher education preparation. 🎓 The average age for Austrians to move out is 25.5 years, with many students like Sebi aspiring to continue their education at nearby universities, such as the University of Vienna. Transportation 🚉 Vienna has an excellent public transport syste...

Why U.S. Tech Giants Are Betting Big on Canadian AI?

  Why U.S. Tech Giants Are Betting Big on Canadian AI Imagine this: the most powerful tech companies in the world—Google, Meta, Microsoft—are betting their futures not just in Silicon Valley, but thousands of miles north, in the snowy cities of Canada. Strange, right? Why would billion-dollar U.S. tech giants rely so heavily on Canadian AI labs? What do Canadian researchers have that the tech capitals of California don’t? And could this quiet dependence shift the global tech balance? Let’s dive into a story of brainpower, policy, and a silent AI revolution that began long before most of us even knew what AI was. The Roots of Canada's AI Advantage To understand why U.S. tech titans are now so deeply entwined with Canada’s AI ecosystem, we need to go back to the early days of AI research—in the 1980s and '90s. At that time, the initial hype around artificial intelligence had faded. Funding was drying up globally, and many dismissed AI, especially deep learning, as a dead en...